Progestin-induced growth hormone (GH) production in the treatment of dogs with congenital GH deficiency

Domestic Animal Endocrinology

Volumn 15, Issue 2, 1998, Pages 93-102

  Kooistra, H S ^a   Voorhout, G ^a   Selman, P J ^a   Rijnberk, A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; GROWTH HORMONE; MEDROXYPROGESTERONE; SOMATOMEDIN C;

ACROMEGALY; ANIMAL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; BLOOD; BODY SIZE; CASE REPORT; COMPARATIVE STUDY; DOG; DOG DISEASE; DRUG EFFECT; FEMALE; FOLLOW UP; GENE INDUCTION; GROWTH HORMONE DEFICIENCY; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HYPOPHYSIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MAMMARY GLAND FUNCTION; METABOLISM; NONHUMAN; NUTRITIONAL DEFICIENCY; PITUITARY DWARFISM; PRURITUS; RADIOGRAPHY; TOMOGRAPHY;

ANIMALS; DOG DISEASES; DOGS; DWARFISM, PITUITARY; FEMALE; FOLLOW-UP STUDIES; GROWTH HORMONE; INJECTIONS, INTRAVENOUS; INSULIN-LIKE GROWTH FACTOR I; MALE; MEDROXYPROGESTERONE; PITUITARY GLAND; PROGESTERONE CONGENERS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032034151     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0739-7240(97)00081-7     Document Type: Article

References (44)

1. 1. Eigenmann JE, Eigenmann RY, Rijnberk A, Van Der Gaag I, Zapf J, Froesch ER. Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocrinol 104:167-176, 1983.
2. 2. Watson ADJ, Rutteman GR, Rijnberk A, Mol JA. Effect of somatostatin analogue SMS 201-995 and antiprogestin agent RU486 in canine acromegaly. Front Horm Res 17:193-198, 1987.
3. 3. Selman PJ, Mol JA, Rutteman GR, Rijnberk A. Progestins and growth hormone excess in the dog. Acta Endocrinol 125[Suppl. 1]:42-47, 1991.
4. 4. Selman PJ, Mol JA, Rutteman GR, Rijnberk A. Progestin treatment in the dog: I. Effects on growth hormone, IGF-I, and glucose homeostasis. Eur J Endocrinol 131:413-421, 1994.
5. 5. Selman PJ, Mol JA, Rutteman GR, Van Garderen E, Rijnberk A. Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134:287-292, 1994.
6. 6. Van Garderen E, De Wit M, Voorhout WF, Rutteman GR, Mol JA, Nederbragt H, Misdorp W. Expression of growth hormone in canine mammary tissue and mammary tumors: Evidence for a potential autocrine/paracrine stimulatory loop. Am J Pathol 150:1037-1047, 1997.
7. 7. Mol JA, Van Garderen E, Selman PJ, Wolfswinkel J, Rijnberk A, Rutteman GR. Growth hormone mRNA in mammary gland tumors of dogs and cats. J Clin Invest 95:2028-2034, 1995.
8. 8. Mol JA, Henzen-Logmans SC, Hageman Ph, Misdorp W, Blankenstein MA, Rijnberk A. Expression of the gene encoding growth hormone in the human mammary gland. J Clin Endocrinol Metab 80:3094-3096, 1995.
9. 9. Mol JA, van Garderen E, Rutteman GR, Rijnberk A. New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: Induction of the local biosynthesis of growth hormone (GH) in the mammary gland of dogs, cats and humans. J Steroid Biochem Molec Biol 57:67-71, 1996.
10. 10. Andresen E, Willeberg P. Pituitary dwarfism in German shepherd dogs: Additional evidence of simple, autosomal recessive inheritance. Nord Vet Med 28:481-486, 1976.
11. 11. Rijnberk A. Hypothalamus-pituitary system. In: Clinical Endocrinology of Dogs and Cats. Rijnberk A (ed). Kluwer Academic Publisher Group, Dordrecht, p. 11-34, 1996.
12. 12. Eigenmann JE, Eigenmann RY. Radioimmunoassay of canine growth hormone. Acta Endocrinol 98:514-520, 1981.
13. 13. Nap RC, Mol JA, Hazewinkel HAW. Age-related plasma concentrations of growth hormone (GH) and insulin-like growth factor I (IGF-I) in Great Dane pups on different dietary levels of protein. Domest Animal Endocrinol 10:237-247, 1993.
14. 14. Okkens AC, Bevers MM, Dieleman SJ, Willemse AH. Shortening of the interoestrous interval and the lifespan of the corpus luteum of the cyclic dog by bromocriptine treatment. Vet Quart 7:173-176, 1985.
15. 15. Arts CJM, Koppeschaar HPE, Veeman W, Thijssen JHH. A direct radioimmunoassay for the determination of adrenocorticotropic hormone (ACTH) and a clinical evaluation. Ann Clin Biochem 22:247-256, 1985.
16. 16. Mol JA, Slob A, Middleton DJ, Rijnberk A. Release of adrenocorticotropin, melanotropin and beta-endorphin by pituitary tumours of dogs with pituitary-dependent hyperadrenocorticism. Front Horm Res 17:61-70, 1987.
17. 17. Nett TM, Akbar AM, Phemister RD, Hoist PA, Reichert LE Jr, Niswender GD. Levels of luteinizing hormone, estradiol and progesterone in serum during the estrous cycle and pregnancy in the beagle bitch. Proc Soc Exp Biol Med 148:136-139, 1982.
18. 18. Williams DA, Scott-Moncrieff JC, Bruner J, Sustarsic D, Panoisan-Sahakian N, Unver E, El Shami AS. Canine serum thyroid-stimulating hormone following induction of hypothyroidism. J Vet Int Med 9:184, 1995.
19. 19. Meij BP, Mol JA, Rijnberk A. Thyroid-stimulating hormone responses after single administration of thyrotropin-releasing hormone and combined administration of four hypothalamic releasing hormones in beagle dogs. Domest Animal Endocrinol 13:465-468, 1996.
20. 20. Eigenmann JE, Zanesco S, Arnold U, Froesch ER. Growth hormone and insulin-like growth factor I in German shepherd dwarf dogs. Acta Endocrinol 105:289-293, 1984.
21. 21. Van Haaften B, Bevers MM, Van den Brom WE, Okkens AC, Van Sluijs FJ, Willemse AH, Dieleman SJ. Increasing sensitivity of the pituitary to GnRH from early to late anoestrus in the beagle bitch. J Reprod Fert 101:221-225, 1994.
22. 22. Meij BP, Mol JA, Hazewinkel HAW, Bevers MM, Rijnberk A. Assessment of a combined anterior pituitary function test in beagle dogs: Rapid sequential intravenous administration of four hypothalamic releasing hormones. Domest Animal Endocrinol 13:161-170, 1996.
23. 23. Muller-Peddinghaus R, El Eltebry MF, Siefert J, Ranke M. Hypophysärer Zwergwuchs beim Deutschen Schäferhund. Vet Pathol 17:406-421, 1980.
24. 24. Willeberg P, Kastrup KW, Andresen E. Pituitary dwarfism in German shepherd dogs: Studies on somatomedin activity. Nord Vet Med 27:448-454, 1975.
25. 25. Feldman EC, Nelson RW. Disorders of growth hormone. In: Canine and Feline Endocrinology and Reproduction, 2nd ed. Feldman EC and Nelson RW (eds). W.B. Saunders Company, Philadelphia, p. 38-66, 1996.
26. 26. Benjamin M. Cysts (large follicles) and colloid in pituitary glands. Gen Comp Endocrinol 45:425-445, 1981.
27. 27. Rijnberk A, Van Herpen H, Mol JA, Rutteman GR. Disturbed release of growth hormone in mature dogs: A comparison with congenital growth hormone deficiency. Vet Quart 133:542-545, 1993.
28. 28. Yoshida T, Shimatsu A, Sakane N, Hizuka N, Horikawa R, Tanaka T. Growth hormone (GH) secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: Nonpulsatile secretion of GH may induce elevated insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels. J Clin Endocrinol Metab 81:310-313, 1996.
29. 29. Juul A, Pedersen SA, Sorensen S, Winkler, K, Jorgensen JOL, Christiansen JS, Skakkebaek NE. Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3. bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset. Eur J Endocrinol 131:41-49, 1994.
30. 30. Mandel S, Moreland E, Nichols V, Hanna C, Lafranchi S. Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment. J Clin Endocrinol Metab 80:190-194, 1995.
31. 31. Wollmann HA, Schönau E, Blum WF, Meyer F, Kruse K, Ranke MB. Dose-dependent responses in insulin-like growth factors, insulin-like growth factor-binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency. Horm Res 43:249-256, 1995.
32. 32. Sokolowski JH, Zimbelman RG. Canine reproduction: Effects of multiple treatments of medroxyprogesterone acetate on reproductive organs of the bitch. Am J Vet Res 35:1285-1287, 1974.
33. 33. Schaefers-Okkens AC. Ovaries, In: Clinical Endocrinology of Dogs and Cats. Rijnberk A (ed). Kluwer Academic Publisher Group, Dordrecht, p. 131-156, 1996.
34. 34. Selman PJ, Wolfswinkel J, Mol JA. Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog. Steroids 61:133-137, 1996.
35. 35. Willemse PHB, Dikkeschei LD, Tjabbes T, Vanveelen H, Sleijfer DT. Adrenal steroids as parameters of the bioavailability of Ma and MPA. Eur J Cancer 26:359-362, 1990.
36. 36. Selman PJ, Mol JA, Rutteman GR, Rijnberk A. Progestin treatment in the dog: I. Effects on the hypothalamic-pituitary-adrenocortical axis. Eur J Endocrinol 131:422-430, 1994.
37. 37. Simononski K, Goss P, Drucker DJ. The Cushing syndrome induced by medroxyprogesterone acetate. Ann Int Med 111:758-760, 1989.
38. 38. Scott DW, Miller WH, Griffin CE. Endocrine and metabolic diseases. In: Muller & Kirk's Small Animal Dermatology (5th ed.) Scott DW, Miller WH, Griffin CE (eds). WB Saunders Company, Philadelphia, p. 627-719, 1995.
39. 39. Peterson ME, Altszuler N. Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment. Am J Vet Res 42:1881-1883, 1981.
40. 40. Giustina A, Wehrenberg WB. The role of glucocorticoids in the regulation of growth hormone secretion. Mechanisms and clinical significance. Trends Endocrinol Metab 3:306-311, 1992.
41. 41. Takahashi H, Bando H, Zhang C, Yamasaki R, Saito S. Mechanism of impaired growth hormone secretion in patients with Cushing's disease. Acta Endocrinol 127:13-17, 1992.
42. 42. Van Herpen H, Rijnberk A, Mol JA. Production of antibodies to biosynthetic human growth hormone in the dog. Vet Rec 134:171, 1994.
43. 43. Ascacio-Martinez JA, Barrera Saldana HA. A dog growth hormone cDNA codes for a mature protein identical to pig growth hormone. Gene 143:277-280, 1994.
44. 44. Eigenmann JE. Diagnosis and treatment of dwarfism in a German shepherd dog. J Am Anim Hosp Ass 17:798-804, 1981.